Abbott Plans 3,000 Job Cuts Tied to Solvay Deal

Abbott Laboratories said it will eliminate 3,000 jobs and take almost $1.3 billion in charges over the next two years as it integrates its Solvay pharmaceuticals business.
The Bellingham Herald